Form 8-K - Current report:
SEC Accession No. 0001437749-25-011309
Filing Date
2025-04-08
Accepted
2025-04-08 08:00:39
Documents
29
Period of Report
2025-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250407_8k.htm   iXBRL 8-K 31693
2 EXHIBIT 99.1 ex_799305.htm EX-99.1 5889
3 EXHIBIT 99.2 ex_799306.htm EX-99.2 987
4 EXHIBIT 99.3 ex_799172.htm EX-99.3 21040
9 a01.jpg GRAPHIC 84043
10 a02.jpg GRAPHIC 99722
11 a03.jpg GRAPHIC 110625
12 a04.jpg GRAPHIC 104695
13 a05.jpg GRAPHIC 108053
14 a06.jpg GRAPHIC 111318
15 a07.jpg GRAPHIC 110698
16 a08.jpg GRAPHIC 118581
17 a09.jpg GRAPHIC 76108
18 a10.jpg GRAPHIC 92563
19 a11.jpg GRAPHIC 84043
20 b01.jpg GRAPHIC 143070
  Complete submission text file 0001437749-25-011309.txt   1940646

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250408.xsd EX-101.SCH 4112
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250408_def.xml EX-101.DEF 13903
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250408_lab.xml EX-101.LAB 18373
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250408_pre.xml EX-101.PRE 13935
31 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250407_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25820310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)